DBD vs ASAN
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Nov 10, 2026
DBD
ASAN
Investment Advisor Scores
ASAN
AI Analyst Insights
Detailed Metrics Comparison
| Metric | DBD | ASAN | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 12.6422 | 23.5849 | DBD |
| PEG Ratio | 0 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 5.2% | 9.9% | ASAN |
| Earnings Growth | -82.9% | 0.0% | ASAN |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 45.3/100 | 31.8/100 | DBD |
| Profit Margin | 2.0% | -18.6% | DBD |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | AVOID NEW MONEY | DBD |
Relative Price Performance (Last 90 Days)
Current Technical Phase
DBD
MarkdownPrice below a falling SMA50 (slope -4.9%), weak momentum, RSI 38
ASAN
NeutralMixed signals - no dominant trend phase, RSI 39
Fundamentals Snapshot
| Metric | DBD | ASAN |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 9.3 | 27.0 |
| Trailing P/E | 28.5 | — |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.1% | 0.1% |
| Gross Margin | 0.3% | 0.9% |
| Operating Margin | 0.1% | -0.2% |
| EPS | 2.11 | -0.66 |
| Dividend Yield | — | — |